Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print June 28, 2002, 10.1148/radiol.2242011322
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2242011322v1
224/2/404    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Erkel, A. R.
Right arrow Articles by Bloem, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Erkel, A. R.
Right arrow Articles by Bloem, J. L.
(Radiology 2002;224:404-409.)
© RSNA, 2002


Gastrointestinal Imaging

Hepatic Metastases in Patients with Colorectal Cancer: Relationship between Size of Metastases, Standard of Reference, and Detection Rates1

Arian R. van Erkel, MD, Milan E. J. Pijl, MD, Annette A. van den Berg-Huysmans, MSc, Martin N. J. M. Wasser, MD, Cornelis J. H. van de Velde, MD and Johan L. Bloem, MD

1 From the Departments of Radiology (A.R.v.E., M.E.J.P., A.A.v.d.B.H., M.N.J.M.W., J.L.B.) and Oncological Surgery (C.J.H.v.d.V.), Leiden University Medical Center, Albinusdreef 2, PO Box 9600, 2300 RC Leiden, the Netherlands. Received August 3, 2001; revision requested September 10; revision received November 14; accepted January 7, 2002. M.E.J.P. supported by the Dutch Cancer Foundation, with a grant for work on the detection of hepatic metastases in patients with colorectal cancer. Address correspondence to A.R.v.E. (e-mail: a.r.van_erkel@lumc.nl).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PURPOSE: To determine the relationship between the size of hepatic metastases, the standard of reference, and the reported detection rate in patients with colorectal cancer.

MATERIALS AND METHODS: With use of a MEDLINE search (January 1994 to January 2001), articles were selected that contained original results on detection of hepatic metastases of colorectal cancer, categorized for size in at least two categories, with use of helical computed tomography (CT), helical CT at arterial portography, or magnetic resonance imaging. Results were compared with the size distribution of hepatic metastases in 47 consecutive patients with colorectal carcinoma, which were detected by using a combination of intraoperative ultrasonography (US) and palpation.

RESULTS: Seven studies met all predefined criteria. Four studies involved intraoperative US in all patients and demonstrated a significant negative correlation (-0.988) between detection rate and fraction of small metastases. These studies had a higher fraction and lower detection rate of small metastases and a lower overall detection rate. A majority (58% [145 of 252]) of metastases in the study population were smaller than 20 mm.

CONCLUSION: Few articles adequately describe the standard of reference and size distribution of hepatic lesions. Hepatic metastases of colorectal cancer are frequently smaller than 20 mm. When the standard of reference is suboptimal, many small metastases are excluded from analysis, and detection rates are therefore inflated.

© RSNA, 2002

Index terms: Colon, CT, 75.12115, 75.12119 • Colon, MR, 75.1214 • Colon, US, 75.12982 • Colon neoplasms, 75.321 • Liver neoplasms, metastases, 761.332 • Technology assessment


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In selected patients with colorectal cancer, surgical resection of or local chemotherapy for hepatic metastases will improve survival (1,2). To select patients who may benefit from these procedures, preoperative imaging to assess data on the character, number, localization, and size of hepatic lesions is essential.

High detection rates for hepatic metastases have been reported for magnetic resonance (MR) imaging, helical computed tomography (CT), and helical CT at arterial portography (CTAP) (36). High (>50%) recurrence rates of metastatic disease distant from resected metastases (7,8), however, suggest that many metastases are small and are missed on preoperative images. Reports on high detection rates may be associated with a suboptimal standard of reference. The quality of the standard of reference is an issue because pathologic-anatomic examination of the entire liver is not possible for both practical and ethical reasons. Investigators in previous studies (9,10) have demonstrated that intraoperative ultrasonography (US) combined with intraoperative palpation of the liver is the best alternative standard of reference.

A suboptimal standard of reference may result in a too-small fraction of small lesions and overestimation of the detection rate. We suggest that the size distribution of the metastases has a major effect on the results and reflects the quality of the standard of reference.

The purpose of our study was to determine the relationship between the size of hepatic metastases, the standard of reference, and the reported detection rate in patients with colorectal cancer.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Patients and Reference Diagnosis
Between September 1994 and June 1998, 47 consecutive patients with colorectal carcinoma underwent surgery for either resection of hepatic metastases (n = 16) or isolated hepatic perfusion via the hepatic artery and portal vein with 200 mg melphalan (Alkeran; Glaxo Wellcome, Utrecht, the Netherlands) (2) when surgical resection was considered impossible (n = 18). In 11 patients with hepatic metastases who underwent surgery, neither resection nor isolated hepatic perfusion was performed, because of extrahepatic tumor localization (n = 6) or surgical technical reasons (n = 5). In two patients, all preoperatively detected lesions turned out to be benign perioperatively. In a prospective study approved by the local medical ethics committee, all patients underwent surgical inspection, palpation, and intraoperative US of the liver after giving informed consent. The entire abdomen, including the surface of the liver, was meticulously inspected. The liver was completely mobilized, inspected, and bimanually palpated by the surgeon for focal hepatic lesions. An experienced radiologist (M.E.J.P., M.N.J.M.W.) performed intraoperative US, without restrictions in examination time. For intraoperative US, we used a 7.5-MHz transducer tailored for intraoperative procedures (model A2000; Aloka, Tokyo, Japan).

Lesions were categorized as either benign or malignant on the basis of characteristic appearance and compressibility at intraoperative US, consistency at palpation, and histologic findings. On the basis of intraoperative US, sharply defined, thin-walled anechoic lesions with increased through transmission were considered benign cysts. Hyperechoic geometrically defined lesions that were compressible at intraoperative US and soft at palpation were considered hemangiomas. Lesions that did not meet these criteria were considered potentially malignant. These were either resected or subjected to fine-needle aspiration biopsy. In addition, histologic confirmation of at least one representative lesion was obtained in each patient. The reference diagnosis was thus based on a combination of palpation and intraoperative US findings, and when the criteria of a benign lesion were not met, it was based on histologic findings. The total number of malignant and benign lesions per patient was recorded.

The maximal diameter of each lesion was recorded by using intraoperative US. The size distribution of malignant and benign lesions was determined by using the following size groups: smaller than 5, 5–9, 10–19, 20–29, 30–39, and 40 mm or larger. For the comparison between size and histologic nature, we used cutoff values of 10 and 20 mm and calculated positive and negative predictive values. Typical benign lesions at intraoperative US and palpation (cysts and hemangiomas) and histologically proven benign lesions that were not classified as typically benign at intraoperative US were combined and analyzed as benign lesions.

Literature Review
We searched MEDLINE literature for articles published between January 1994 and January 2001 that were limited to humans and the English language. We used the following search: (a) liver neoplasms (subject headings: diagnosis and radiography); (b) tomography, x-ray computed (all subject headings); (c) MR imaging (all subject headings); (d) combine a and b; (e) combine a and c; (f) combine d or e. The titles of the articles found were screened. An article was selected when the title mentioned detection or characterization of hepatic lesions with MR imaging and/or CT. The bibliographies of the selected articles were searched for articles on the same topic that were not found with the MEDLINE search.

The articles were reviewed and selected by A.R.v.E. The abstract, methods, and results sections of all selected papers were read, and an article was definitely selected for analysis when all of the following criteria were met: (a) The article contained original results on the detection of hepatic metastases of colorectal cancer; (b) helical CT (in portal and/or arterial phase following administration of intravenous contrast agents), helical CTAP, and/or MR imaging were used as the diagnostic modalities; (c) The study involved at least 10 patients; (d) size-specific detection of hepatic lesions was provided for at least two size categories (eg, for lesions < 2 or <= 2 cm). For each category, the detection rate and actual number of lesions were specifically stated.

For the analysis, only the mean number, detection rates, and size distribution of hepatic metastases were included. Benign or other malignant lesions were not included. The mean number of metastases, the overall detection rate, and detection rate per size stratum were compared with the size distribution of hepatic metastases in patients with colorectal carcinoma, as determined in the patient population of the current study. Since the threshold value of 10 mm was used most consistently in the articles that met all criteria, this threshold value was used for the analyses per size stratum. When detection rates of more than one imaging modality were reported, the maximal detection rate reported was used for analysis. When two imaging modalities were combined and separate detection rates could not be discerned from the report, the combination of modalities was used.

Statistical Analysis
To determine the relationship between the size and histologic nature of the hepatic lesions in the patients in the current study, the sizes of malignant and benign lesions, as measured with intraoperative US, were compared by using the median test. To determine if, in published reports, the reported detection rates correlated with the fraction of small (<10-mm) metastases, the two-tailed Pearson correlation test was used.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Size of Hepatic Lesions and Correlation with Histologic Nature
In 47 patients, we detected a total of 355 hepatic lesions (252 malignant and 103 benign). No patients were excluded from the analysis. The median number of malignant lesions per patient was 4.0 (mean, 5.4; range, 0–25), and the median number of benign lesions per patient was 1.0 (mean, 2.2; range, 0–17). The 13-mm median diameter of malignant lesions (mean, 21.0 mm ± 22.1 [SD]; range, 2–140 mm) was significantly larger (P < .001; median test) than the 8-mm median diameter of benign lesions (mean, 11.7 mm ± 16.9; range, 2–130 mm). The size distribution of benign and malignant lesions is demonstrated in Figure 1. Of all metastases, 58% (145 of 252) were smaller than 20 mm, 30% (76 of 252) were smaller than 10 mm, and 8% (19 of 252) were smaller than 5 mm.



View larger version (25K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. Histogram shows size distribution of 355 focal hepatic lesions in 47 patients with colorectal cancer who underwent surgery for resection of metastases or for isolated hepatic perfusion.

 
When a lesion of 20 mm or larger was considered malignant and a lesion smaller than 20 mm was considered benign, the positive predictive value for malignancy was 91% (107 of 118 lesions), and the negative predictive value was 39% (92 of 237 lesions). When 10 mm was used as a cutoff value to predict malignancy, the positive and negative predictive values were 80% (176 of 220 lesions) and 44% (59 of 135 lesions), respectively.

Literature Review
The MEDLINE search resulted in a total of 1,442 articles. From these and the bibliographies of the selected articles, 155 articles were selected for further reading on the basis of their titles. Detection rates for hepatic metastases of colorectal cancer (criterion a) were not provided in 141 of the articles. In 41 of these 141 articles, detection rates were reported for hepatic lesions not solely consisting of metastases of colorectal cancer. Of these 41 articles, 13 included size-categorized detection rates.

In 14 studies (35,1121), detection rates for hepatic metastases of colorectal cancer were reported. One study (17) was excluded on the basis of criterion b. In this study, the detection rate for dynamic incremental CT was reported. Five more studies (4,1821) were excluded because no size-stratified detection rates were reported. Only eight studies (3,5,1116) met all predefined criteria. The article by Schmidt et al (16) was excluded from the analysis, since it was based on the same data as the earlier article by Strotzer et al (13). The results of the seven remaining studies are summarized in the Table. It is remarkable that all seven studies involved intraoperative US as the standard of reference—in four studies (11,12,14,15) in all patients and in three studies (3,5,13) in part of the patient population. The overall recalculated detection rate of these seven studies was 75% (389 of 516 metastases). The mean number of metastases per patient in the seven reviewed studies was 2.3 (516 divided by 220; range, 1.5–3.6). In the three studies in which intraoperative US was performed in only part of the population (3,5,13), the mean number of metastases per patient was 1.7 (175 divided by 106). In the four studies in which intraoperative US was performed in all patients (11,12,14,15), the mean number of metastases per patient was 3.0 (341 divided by 114).


View this table:
[in this window]
[in a new window]

 
Detailed Results of Seven Studies that Met All Predefined Criteria

 
Figure 2 demonstrates the correlation between the highest reported detection rate in the articles and the fraction of metastases smaller than 10 mm. Strotzer et al (13) reported a high detection rate of 96% (51 of 53 metastases) for a combination of helical CT and helical CTAP in a group of patients with a large fraction (53% [28 of 53]) of metastases 10 mm or smaller (13). In that study, intraoperative US was performed in only 21 of 35 patients. Intraoperative US was also used in part of the study populations of Soyer et al (3) and Hamm et al (5), who reported helical CTAP and MR imaging detection rates, respectively, of 85%–98% in patient groups with a small fraction of small metastases (3,5). These three studies, in which intraoperative US was selectively used, are indicated by shaded markers in Figure 2.



View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2. Graph shows correlation between the highest reported detection rate and the fraction of metastases smaller than 10 mm. In three studies (solid markers), intraoperative US was used in only part of the population. In the other four studies (open markers), intraoperative US was used in all patients. A higher fraction of small metastases was associated with a lower detection rate (two-tailed Pearson correlation test, -0.988; P = .012).

 
In the remaining four studies (11,12,14,15), all patients underwent intraoperative US. These studies are indicated by open markers in Figure 2. When these four studies are considered, a higher fraction of small metastases is associated with a lower detection rate, with a two-tailed Pearson correlation test rate of -0.988 (P = .012). Lencioni et al (14) reported a high detection rate of 94% (34 of 36 metastases) for helical CTAP. In that study, however, the fraction of hepatic metastases of 10 mm or smaller was only 25% (nine of 36). The authors of the three remaining studies (11,12,15) reported MR imaging detection rates of only 55%–69% (mean, 61%; 186 of 305 metastases) but also demonstrated a large fraction of small metastases (38%–45% < 10 mm). When only studies with a fraction of small (<10-mm) metastases of at least 30% (1113,15), the fraction in the current study population, are considered, the recalculated detection rate decreases from 75% to 66% (273 of 358 metastases). The maximal detection of hepatic metastases smaller than 10 mm in the seven articles was 16%–100%. The maximal reported detection rates of small metastases in studies in which intraoperative US was used in part of the population were 71% (five of seven) (3), 93% (26 of 28) (13), and 100% (22 of 22) (5). In studies in which intraoperative US was used in all patients, the maximal detection rates of small hepatic metastases were 16% (10 of 61) (12), 24% (four of 17) (11), 31% (15 of 49) (15), and 78% (seven of nine) (14).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the current study of patients with colorectal cancer and hepatic metastases, at the time of clinical decision making, a majority (58% [145 of 252]) of metastases were smaller than 20 mm, and 30% (76 of 252) were smaller than 10 mm. The quality of the standard of reference in studies on the detection of hepatic metastases should be high enough to ensure inclusion of these small metastases.

The quality of the standard of reference is crucial in reports on detecting hepatic metastases of colorectal cancer. Pathologic examination of the entire liver is not an option, and pathologic examination of the resected hepatic specimen alone will result in overestimation of the detection rate, since part of the liver is not subjected to the standard of reference (verification bias). The best alternative standard of reference consists of surgical inspection and palpation, in combination with intraoperative US performed by an experienced radiologist and histologic confirmation when the nature of a lesion is unclear (9,10). It is, therefore, no surprise that the seven studies on the detection of hepatic metastases that fulfilled all criteria for analysis (3,5,1115) all involved intraoperative US as the standard of reference. This standard of reference by no means enables detection of all hepatic metastases. The lower limit in our patient group was 2 mm, and only 8% (19 of 252) of metastases were smaller than 5 mm. Also, lesions larger than 5 mm may occasionally be missed. Even with this standard of reference, the detection rates of the evaluated imaging modalities will be overestimated.

The size distribution of hepatic metastases is indicative of the quality of the standard of reference. In reporting the detection rate of an imaging modality for hepatic metastases, it is therefore equally important to adequately describe the standard of reference used and the size distribution of hepatic metastases, preferably with size-stratified detection rates. In recent literature, only a few studies (3,5,1116) meet these criteria.

Of the eight studies that met our predefined criteria (3,5,1116), the study by Schmidt et al (16) was excluded from the analysis, since it was based on the same data as the study by Strotzer et al (13). The seven remaining studies (3,5,1115) demonstrated great variance in the fraction of metastases smaller than 10 mm (25%–53%) and in detection rates (55%–98%). The four studies in which intraoperative US was performed in all patients (11,12,14,15) demonstrated a significant negative correlation between detection rate and fraction of small metastases (two-tailed Pearson correlation test, -0.988). Although this correlation was statistically significant (P = .012), it was based on only four studies; thus, it was heavily influenced by each value. A greater fraction of small metastases was associated with a lower detection rate of hepatic metastases. In general, the studies in which intraoperative US was performed in all patients (11,12,14,15) had a higher fraction of small hepatic metastases, a lower detection rate for small metastases, and a lower overall detection rate, as compared with the studies in which intraoperative US was performed in a part of the population (3,5,13). Only Lencioni et al (14) reported a high detection rate of 94% (34 of 36) for helical CTAP in a study with a complete standard of reference (14). The fraction of small (<=10-mm) metastases in that study was, however, smaller than the fraction of small metastases in the three MR imaging studies in which intraoperative US was performed in all patients (11,12,15). The lower detection rates in these studies, as compared with that in the study by Lencioni et al (14), can be explained by the smaller fraction of small metastases in the population described by the latter authors.

The outlier in the seven studies was the study by Strotzer et al (13). The combination of helical CT and CTAP resulted in detection rates of 96% (51 of 53) for all metastases and 93% (26 of 28) for metastases 10 mm or smaller. Despite the fact that in the study by Strotzer et al intraoperative US was performed in only 21 of the 35 patients, the fraction of metastases 10 mm or smaller was as high as 53% (28 of 53). One can only speculate about the reason for this. The combination of helical CT and CTAP may indeed lead to increased detection of small metastases. A standard of reference not used independently of the tested imaging modalities might then result in a high fraction of small metastases. However, the low mean number of metastases per patient of 1.5 (35 of 53) in that study may also reflect a different patient population.

The mean number of metastases per patient (5.4) in the current study population was high, as compared with that (2.3) in the seven reviewed studies (3,5,1115). For the three studies in which intraoperative US was performed in only part of the population (3,5,13), this difference can be explained by the quality of the standard of reference. In the four remaining studies (11,12,14,15), intraoperative US was performed in all patients, and the standards of reference were identical. Patient selection might play a role in the differences in the number of metastases per patient. In 62% (29 of 47) of the patients in the current study, resection of metastases was considered impossible. In the study by Hagspiel et al (11), all 13 patients underwent partial hepatic resection. In the other three studies (12,14,15), data were insufficient to determine the fraction of patients considered able to undergo surgery.

The current study was limited by the fact that only seven articles could be used for final analysis. Since only English-language literature was analyzed, relevant articles in other languages may have been missed. Only four studies (11,12,14,15) that fulfilled all criteria for inclusion involved intraoperative US in all patients and were used to determine the correlation between size and detection rates.

A secondary finding in the evaluation of the patients in the current study with colorectal cancer was that size is partially helpful in characterizing focal hepatic lesions in patients with colorectal cancer and hepatic metastases. Lesions 20 mm or larger were most likely to be metastases, with a positive predictive value for malignancy of 91% (107 of 118 lesions). The negative predictive value, however, was only 39% (92 of 237 lesions). Characterization of focal hepatic lesions smaller than 20 mm is not possible on the basis of size alone, because a majority of benign lesions are, as metastases, smaller than 20 mm.

Our review of the literature demonstrates that only a few articles, in which the detection rate of modern imaging modalities for hepatic metastases is reported, have adequate description of the standard of reference and size distribution of the studied lesions. In studies on the detection rate of hepatic metastases in patients with colorectal cancer, the quality of the standard of reference determines the size distribution of hepatic metastases and therefore the reported detection rates. Detection rates are lower in studies with a high-quality reference standard and therefore a larger fraction of small metastases.


    ACKNOWLEDGMENTS
 
We thank the Dutch Cancer Foundation, which supported M.E.J.P. with a grant for research on the detection of hepatic metastases in patients with colorectal cancer.


    FOOTNOTES
 
Abbreviation: CTAP = CT at arterial portography

Author contributions: Guarantor of integrity of entire study, A.R.v.E.; study concepts and design, A.R.v.E., M.E.J.P., A.A.v.d.B.H., M.N.J.M.W.; literature research, A.R.v.E., M.E.J.P.; clinical studies, A.R.v.E., M.E.J.P., M.N.J.M.W., C.J.H.v.d.V.; data acquisition, A.R.v.E., M.E.J.P.; data analysis/interpretation, A.R.v.E., M.E.J.P., A.A.v.d.B.H.; statistical analysis, A.R.v.E., M.E.J.P., A.A.v.d.B.H.; manuscript preparation, A.R.v.E., J.L.B.; manuscript definition of intellectual content, all authors; manuscript editing, A.R.v.E., J.L.B., M.N.J.M.W.; manuscript revision/review, A.R.v.E., M.E.J.P., J.L.B., M.N.J.M.W.; manuscript final version approval, all authors.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993; 71:4252-4266.[CrossRef][Medline]
  2. Vahrmeijer AL, van Dierendonck JH, Keizer HJ, et al. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. Br J Cancer 2000; 82:1539-1546.[CrossRef][Medline]
  3. Soyer P, Bleumke DA, Hruban RH, Sitzmann JV, Fishman EK. Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography. Radiology 1994; 193:71-74.[Abstract/Free Full Text]
  4. Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999; 213:86-91.[Abstract/Free Full Text]
  5. Hamm B, Mahfouz AE, Taupitz M, et al. Liver metastases: improved detection with gadolinium-enhanced MR imaging. Radiology 1997; 202:677-682.[Abstract/Free Full Text]
  6. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PIM, Borel Rinkes IHM, Wiggers T. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 1997; 203:449-456.[Abstract/Free Full Text]
  7. Harned RK, II, Chezmar JL, Nelson RC. Recurrent tumor after resection of hepatic: metastases from colorectal carcinoma—location and time of discovery as determined by CT. AJR Am J Roentgenol 1994; 163:93-97.[Abstract/Free Full Text]
  8. Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuge T, Takayama T. Pattern of recurrence after hepatic resection for colorectal cancer. Br J Surg 1993; 80:1032-1035.[Medline]
  9. Stewart PJ, Chu JM, Kos CS, Chapuis PH, Bokey EL. Intra-operative ultrasound for the detection of hepatic metastases from colorectal cancer. Aust N Z J Surg 1993; 63:530-534.[Medline]
  10. Machi J, Isomoto H, Korohiji T, et al. Accuracy of intraoperative ultrasonography in diagnosing liver metastases from colorectal cancer: evaluation with postoperative follow-up results. World J Surg 1991; 15:551-557.[CrossRef][Medline]
  11. Hagspiel KD, Neidl KW, Eicherberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196:471-478.[Abstract/Free Full Text]
  12. Pijl MEJ, Wasser MNJM, van Persijn van Meerten EL, et al. Comparison of inversion-recovery gradient- and spin-echo and fast spin-echo techniques in the detection and characterization of liver lesions. Radiology 1998; 209:427-434.[Abstract/Free Full Text]
  13. Strotzer M, Gmeinwieser J, Schmidt J, et al. Diagnosis of liver metastases with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol 1997; 38:986-992.[Medline]
  14. Lencioni R, Donati F, Cioni D, Paolicchi A, Cicorelli A, Bartolozzi C. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. MAGMA 1998; 7:76-87.
  15. Ward J, Chen F, Guthrie JA, et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 2000; 214:159-166.[Abstract/Free Full Text]
  16. Schmidt J, Strotzer M, Fraunhofer S, Boedeker H, Zirngibl H. Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion by lesion analysis. World J Surg 2000; 24:43-48.[CrossRef][Medline]
  17. van Ooijen B, Oudkerk M, Schmitz PIM, Wiggers T. Detection of liver metastases from colorectal carcinoma: is there a place for routine computed tomography arteriography? Surgery 1996; 119:511-516.[CrossRef][Medline]
  18. Valls C, Lopez E, Guma A, et al. Helical CT versus CT arterial portography in the detection of hepatic metastases of colorectal carcinoma. AJR Am J Roentgenol 1998; 170:1341-1347.[Abstract/Free Full Text]
  19. Valls C, Andia E, Sanchez A, et al. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 2001; 218:55-60.[Abstract/Free Full Text]
  20. Milsom JW, Jerby BL, Kessler H, Hale JC, Herts BR, O’Malley CM. Prospective, blinded comparison of laparoscopic ultrasonography vs. contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery. Dis Colon Rectum 2000; 43:44-49.
  21. Said B, McCart JA, Libutti SK, Choyke PL. Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence. Magn Reson Imaging 2000; 18:305-309.[CrossRef][Medline]



This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
H. J. Kim, K. W. Kim, J. H. Byun, H. J. Won, Y. M. Shin, P. N. Kim, M.-S. Lee, and M.-G. Lee
Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Am. J. Roentgenol., April 1, 2006; 186(4): 1059 - 1066.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. W. Kim, A. Y. Kim, T. K. Kim, S. H. Park, H. J. Kim, Y. K. Lee, M.-S. Park, H. K. Ha, P. N. Kim, J. C. Kim, et al.
Small (l.e. 2cm) Hepatic Lesions in Colorectal Cancer Patients: Detection and Characterization on Mangafodipir Trisodium-Enhanced MRI
Am. J. Roentgenol., May 1, 2004; 182(5): 1233 - 1240.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2242011322v1
224/2/404    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Erkel, A. R.
Right arrow Articles by Bloem, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Erkel, A. R.
Right arrow Articles by Bloem, J. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE